Health Sciences Acquisitions Corp 2 (HSAQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | HSAQ | TNYA | PRQR | ||
| Company | Health Sciences Acquisitions Corp 2 | Tenaya Therapeutics Inc | Proqr Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 10.80 | 1.9900 | 1.7900 | ||
| High | 13.50 | 2.0300 | 1.9300 | ||
| Low | 10.44 | 1.9800 | 1.7600 | ||
| Last | 13.31 | 2.0200 | 1.7800 | ||
| Change | +2.68 | +0.0800 | -0.0200 | ||
| % Change | +25.21% | +4.12% | -1.11% | ||
| Volume | 119,600 | 224,500 | 124,000 | ||
| 20-Day Average Volume | 176,860 | 413,160 | 106,945 | ||
| Previous Close | 10.63 | 1.9400 | 1.8000 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 10.24 | 2.2200 | 1.8353 | ||
| 20-Day Raw Stochastic | 88.84% | 13.73% | 31.71% | ||
| 20-Day Relative Strength | 95.30% | 37.80% | 43.70% | ||
| Weighted Alpha | +2.40 | -50.52 | +17.62 | ||
| Today's Opinion | 100% Buy | 100% Sell | 88% Sell | ||
| Previous Opinion | 100% Buy | 100% Sell | 88% Sell | ||
| Last Month's Opinion | 88% Buy | 100% Sell | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +32.83% since 01/19/23 | -7.76% since 09/19/24 | unch since 09/19/24 | ||
| Low | 9.67 on 01/20/23 | 1.9000 on 09/24/24 | 1.6500 on 09/24/24 | ||
| High | 13.80 on 01/25/23 | 2.2300 on 09/20/24 | 2.0500 on 09/25/24 | ||
| 1-Month | |||||
| %Chg | +33.50% since 12/21/22 | -30.34% since 08/26/24 | -13.59% since 08/26/24 | ||
| Low | 9.41 on 01/19/23 | 1.8800 on 09/16/24 | 1.6500 on 09/24/24 | ||
| High | 13.80 on 01/25/23 | 2.9600 on 08/27/24 | 2.0600 on 08/30/24 | ||
| 3-Month | |||||
| %Chg | +33.30% since 10/26/22 | -25.74% since 06/26/24 | +7.88% since 06/26/24 | ||
| Low | 9.41 on 01/19/23 | 1.8800 on 09/16/24 | 1.6100 on 07/03/24 | ||
| High | 13.80 on 01/25/23 | 4.0600 on 07/26/24 | 2.3500 on 08/15/24 | ||
| 6-Month | |||||
| %Chg | +32.83% since 07/26/22 | -58.18% since 03/26/24 | -25.83% since 03/26/24 | ||
| Low | 9.41 on 01/19/23 | 1.8800 on 09/16/24 | 1.6100 on 07/03/24 | ||
| High | 13.80 on 01/25/23 | 5.3200 on 03/28/24 | 2.4700 on 03/28/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 149,232 | 152,325 | 146,439 | ||
| Shares Outstanding, K | 11,212 | 78,518 | 81,355 | ||
| Annual Sales | 0 | 0 | 7,050,000 | ||
| Annual Net Income | -380,000 | -124,080,000 | -30,430,000 | ||
| Last Quarter Sales | 0 | 0 | 6,790,000 | ||
| Last Quarter Net Income | -876,722 | -29,430,000 | -2,900,000 | ||
| 60-Month Beta | 0.09 | 2.38 | 0.39 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.34 on 08/08/24 | -0.03 on 08/08/24 | ||
| Latest Earnings Date | N/A | 11/13/24 | 11/05/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||